Uterine cancers such as papillary serous carcinoma, clear cell carcinoma, or carcinosarcoma are more likely to have already spread when diagnosed. If the biopsy done before surgery shows a high-grade ...

Only about 3% of uterine cancers are uterine sarcoma. Other less common uterine cancers are uterine papillary serous carcinoma, clear cell carcinoma and carcinosarcoma (also called malignant mixed ...

A laparoscopic image of the pelvis shows the fallopian tube (A), ovary (B), uterus ... carcinoma Malignant Reproductive age or postmenopausal CA-125 Believed to be a subtype of high-grade serous ...

ENDOLA was a phase 1/2 open-label, dose-escalation trial evaluating olaparib with metronomic cyclophosphamide and metformin in elderly, heavily pretreated patients with recurrent advanced endometrial ...

The case group included women with endometrioid adenocarcinoma or other types such as clear cell carcinoma of the endometrium, endometrial stromal sarcoma, serous carcinoma ... assign the predicted ...

CCC has a worse prognosis than endometrioid carcinoma (P = 0.002), and there is no significant difference when compared with uterine papillary serous carcinoma (P = 0.155). CCC can occur in different ...

The efficacy and safety of ZN-c3 is currently being evaluated in adult women with recurrent or persistent uterine serous carcinoma in an ongoing open-label, multicenter phase 2 study ...

1 The study explored the use of carboplatin and paclitaxel chemotherapy with or without trastuzumab in patients with advanced or recurrent uterine serous papillary carcinoma who had overexpressed HER2 ...

We experienced a case of serous tubal intraepithelial carcinoma (STIC), which is the ... examination shows a cystic lesion with papillary projections (yellow arrow) in the left adnexa, next to the ...

Use of chemotherapy or vaginal brachytherapy (VBT) may improve survival among patients with early-stage uterine papillary serous carcinoma. Use of chemotherapy or vaginal brachytherapy (VBT ...